Laxido Orange

Macrogol 3350, the active ingredient in Laxido Orange, is an osmotic laxative presented as an oral solution for oral administration. It works by retaining water in the intestinal lumen, thereby softening stool and promoting regular bowel movements. The product is used to alleviate constipation and occasional bowel irregularity in adults and, when prescribed, in pediatric patients.

GNH USA supplies Laxido Orange as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing reliable sourcing for this European‑market osmotic laxative.

Laxido Orange, an osmotic laxative, is employed to manage conditions affecting bowel transit and stool consistency.

- Constipation: softens stool and facilitates regular bowel movements in individuals with infrequent or difficult evacuation. - Occasional bowel irregularity: provides temporary relief for sporadic irregularity without chronic use. - Functional constipation: improves stool frequency and consistency in functional bowel disorders.

Laxido Orange may be associated with a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Abdominal bloating: sensation of fullness or swelling in the abdomen. - Flatulence: increased intestinal gas production. - Diarrhoea: loose, watery stools occurring more frequently. - Nausea: mild feeling of queasiness.

Serious or Rare Side Effects: - Severe dehydration: marked loss of body fluids requiring medical attention. - Electrolyte imbalance: abnormal levels of sodium, potassium or chloride that may cause cardiac or neurological symptoms.

When using Laxido Orange, certain precautions should be observed to ensure safe and effective therapy. - Assess renal function: patients with impaired kidney function may require monitoring of fluid and electrolyte status. - Evaluate electrolyte balance: individuals on diuretic therapy or with existing electrolyte disorders should be reviewed before initiation. - Limit duration of use: avoid prolonged continuous use without medical supervision to prevent dependence. - Monitor for abdominal pain: persistent or severe abdominal discomfort warrants clinical assessment. - Store at ambient temperature: keep below 25°C, retain in original container, protect from moisture and direct sunlight.

Laxido Orange can interact with other medicines, influencing their absorption or electrolyte balance.

Major Interactions (Avoid): - Digoxin: increased risk of toxicity due to electrolyte shifts, especially potassium loss. - Lithium: enhanced lithium reabsorption may raise serum levels and precipitate toxicity.

Moderate Interactions (Monitor Closely): - Antacids containing aluminium or magnesium: may reduce the laxative’s efficacy by binding. - Oral antibiotics (e.g., tetracyclines): concurrent use may diminish antibiotic absorption. - Diuretics: combined effect on fluid and electrolyte balance may require dose adjustment.